Search results
FDA denies Ipsen's citizen petition for blockbuster drug Somatuline
Endpoints News· 7 days agoUS drug regulators have turned down Ipsen’s effort to slow down generic competition for its blockbuster drug Somatuline Depot, which is used to slow the growth of some tumors ...
Why Do We Eat Popcorn At The Cinema?
Winston-Salem Journal· 3 days agoPopcorn and the cinema go together like peanut butter and jelly; it's hard to imagine a more perfect combination. Popcorn became a staple at fairs,...
Where Will Viking Therapeutics Be in 5 Years?
Motley Fool via Yahoo Finance· 6 days agoThose costs will increase as the company advances its drug candidates into later stages and also as it commercializes them (assuming they obtain...
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
Motley Fool via Yahoo Finance· 2 days agoOver this period, the company intends to launch 20 new medicines, a number of which supposedly have...
Here's Why Shareholders Should Examine Crescita Therapeutics Inc.'s (TSE:CTX) CEO Compensation...
Simply Wall St. via Yahoo Finance· 1 day agoAlthough we don't have analyst forecasts, you might want to assess this data-rich visualization of...
What’s Next For AI Investing: Taking Cues From Nvidia’s Earnings, Stock Split
Forbes· 2 days agoNvidia’s blockbuster earnings report clearly signals that the AI spending boom shows no signs of...
How digital health companies are capitalizing on the GLP-1 boom
CNBC· 6 days agoNovo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 active...
These legislative committees do no legislating. Their leaders get paid extra anyway. - The Boston...
The Boston Globe· 5 hours agoDuring the current two-year legislative session, neither of Montigny’s committees has held a single...
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Stifel Financial Corp.'s...
Simply Wall St. via Yahoo Finance· 1 day agoWe've identified 2 warning signs for Stifel Financial that investors should be aware of in a dynamic...
Should Shareholders Reconsider Upland Software, Inc.'s (NASDAQ:UPLD) CEO Compensation Package?
Simply Wall St. via Yahoo Finance· 1 day agoWe've identified 3 warning signs for Upland Software that investors should be aware of in a dynamic...
